Related Experiment Video
Updated: Sep 22, 2025
08:33
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
Published on: January 5, 2024
1.3K
Demystifying Buprenorphine with Current Evidence-Based Practice in Acute and Chronic Pain Management.
Sarah E Giron1, Gloria Lai2, Charles A Griffis3
1is an academic and clinical instructor, Kaiser Permanente School of Anesthesia.
AANA Journal
|May 23, 2022
Summary
Buprenorphine, a full mu-opioid agonist, is an effective pain management tool for acute and chronic pain, including surgical and cancer pain. Misinterpretations of its receptor activity have limited its use, but evidence supports its efficacy with fewer side effects than traditional opioids.
Area of Science:
- Pharmacology
- Pain Management
- Anesthesiology
Background:
- Buprenorphine is widely used in medication-assisted treatment (MAT).
- Clinical application in pain management is limited by misinterpretation of its mu-opioid receptor activity.
- Preclinical and animal data have led to misconceptions about buprenorphine's efficacy and safety.
Purpose of the Study:
- To review buprenorphine's receptor pharmacology and pharmacokinetics.
- To clarify misinterpretations regarding its intrinsic mu-opioid receptor activity, analgesic ceiling effect, and efficacy.
- To explain differences between buprenorphine and Suboxone and their specific applications in pain management.
Main Methods:
- Review of buprenorphine's receptor pharmacology and pharmacokinetics.
- Analysis of existing clinical evidence on buprenorphine's analgesic effects.
- Comparison of buprenorphine with traditional opioids and other MAT medications.
Main Results:
- Buprenorphine acts as a full mu-opioid agonist with a favorable side effect profile.
- Evidence supports buprenorphine's effectiveness in treating acute and chronic pain, including surgical, cancer, and neuropathic pain.
- Clarification of its mu-opioid receptor activity and analgesic ceiling effect demonstrates its potential for broader pain management.
Conclusions:
- Buprenorphine is a safe and effective analgesic with potential for expanded use in pain management.
- Addressing misinterpretations of its pharmacology is crucial for optimizing its clinical application.
- Guidelines for surgical patients on buprenorphine are discussed, highlighting its utility in diverse pain scenarios.
More Related Videos
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
456
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
456
01:25Analgesia and Pain Management
834
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
834
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
387
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
387
01:22Opioid Receptors: Overview
2.1K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.1K
01:29Local Anesthetics: Clinical Application as Epidural Anesthesia
510
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
510
01:15Drug Abuse and Addiction: Pharmacological Phenomena
759
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
759